vs
Harmony Biosciences Holdings, Inc.（HRMY）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是Harmony Biosciences Holdings, Inc.的1.5倍（$362.7M vs $243.8M），Harmony Biosciences Holdings, Inc.净利率更高（9.2% vs -10.7%，领先19.9%），Harmony Biosciences Holdings, Inc.自由现金流更多（$126.0M vs $-193.1M），过去两年Harmony Biosciences Holdings, Inc.的营收复合增速更高（25.6% vs 17.4%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
HRMY vs VNET — 直观对比
营收规模更大
VNET
是对方的1.5倍
$243.8M
净利率更高
HRMY
高出19.9%
-10.7%
自由现金流更多
HRMY
多$319.1M
$-193.1M
两年增速更快
HRMY
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $362.7M |
| 净利润 | $22.5M | $-38.7M |
| 毛利率 | 71.9% | 20.9% |
| 营业利润率 | 15.8% | 0.5% |
| 净利率 | 9.2% | -10.7% |
| 营收同比 | 21.1% | — |
| 净利润同比 | -54.6% | — |
| 每股收益（稀释后） | $0.38 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRMYVNET
| Q4 25 | $243.8M | — | ||
| Q3 25 | $239.5M | $362.7M | ||
| Q2 25 | $200.5M | — | ||
| Q1 25 | $184.7M | $309.5M | ||
| Q4 24 | $201.3M | — | ||
| Q3 24 | $186.0M | $302.2M | ||
| Q2 24 | $172.8M | $274.4M | ||
| Q1 24 | $154.6M | $262.9M |
净利润HRMYVNET
| Q4 25 | $22.5M | — | ||
| Q3 25 | $50.9M | $-38.7M | ||
| Q2 25 | $39.8M | — | ||
| Q1 25 | $45.6M | $-2.4M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $46.1M | $-2.1M | ||
| Q2 24 | $11.6M | $-1.1M | ||
| Q1 24 | $38.3M | $-22.0M |
毛利率HRMYVNET
| Q4 25 | 71.9% | — | ||
| Q3 25 | 75.1% | 20.9% | ||
| Q2 25 | 81.0% | — | ||
| Q1 25 | 82.7% | 25.2% | ||
| Q4 24 | 73.0% | — | ||
| Q3 24 | 77.0% | 23.2% | ||
| Q2 24 | 81.4% | 21.3% | ||
| Q1 24 | 82.2% | 21.6% |
营业利润率HRMYVNET
| Q4 25 | 15.8% | — | ||
| Q3 25 | 27.3% | 0.5% | ||
| Q2 25 | 24.0% | — | ||
| Q1 25 | 30.4% | 0.1% | ||
| Q4 24 | 27.7% | — | ||
| Q3 24 | 33.2% | 24.5% | ||
| Q2 24 | 12.4% | 0.2% | ||
| Q1 24 | 33.7% | 0.2% |
净利率HRMYVNET
| Q4 25 | 9.2% | — | ||
| Q3 25 | 21.2% | -10.7% | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 24.7% | -0.8% | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 24.8% | -0.7% | ||
| Q2 24 | 6.7% | -0.4% | ||
| Q1 24 | 24.8% | -8.4% |
每股收益（稀释后）HRMYVNET
| Q4 25 | $0.38 | — | ||
| Q3 25 | $0.87 | — | ||
| Q2 25 | $0.68 | — | ||
| Q1 25 | $0.78 | — | ||
| Q4 24 | $0.85 | — | ||
| Q3 24 | $0.79 | — | ||
| Q2 24 | $0.20 | — | ||
| Q1 24 | $0.67 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $492.1M |
| 总债务越低越好 | $163.7M | — |
| 股东权益账面价值 | $870.2M | $890.8M |
| 总资产 | $1.3B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资HRMYVNET
| Q4 25 | $775.3M | — | ||
| Q3 25 | $672.6M | $492.1M | ||
| Q2 25 | $565.3M | — | ||
| Q1 25 | $507.0M | $544.3M | ||
| Q4 24 | $467.2M | — | ||
| Q3 24 | $410.5M | $219.5M | ||
| Q2 24 | $346.9M | $247.2M | ||
| Q1 24 | $372.4M | $246.9M |
总债务HRMYVNET
| Q4 25 | $163.7M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $172.1M | — | ||
| Q1 25 | $175.7M | — | ||
| Q4 24 | $179.3M | — | ||
| Q3 24 | $182.8M | $1.2B | ||
| Q2 24 | $186.4M | — | ||
| Q1 24 | $190.0M | — |
股东权益HRMYVNET
| Q4 25 | $870.2M | — | ||
| Q3 25 | $835.1M | $890.8M | ||
| Q2 25 | $773.1M | — | ||
| Q1 25 | $720.5M | $927.8M | ||
| Q4 24 | $659.2M | — | ||
| Q3 24 | $596.8M | $902.9M | ||
| Q2 24 | $538.6M | $900.6M | ||
| Q1 24 | $515.4M | $895.1M |
总资产HRMYVNET
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $6.1B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | $5.4B | ||
| Q4 24 | $999.2M | — | ||
| Q3 24 | $928.1M | $4.3B | ||
| Q2 24 | $858.4M | $4.0B | ||
| Q1 24 | $847.0M | $3.9B |
负债/权益比HRMYVNET
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.31× | 1.28× | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $126.0M | $-193.1M |
| 自由现金流率自由现金流/营收 | 51.7% | -53.2% |
| 资本支出强度资本支出/营收 | 0.0% | 84.6% |
| 现金转化率经营现金流/净利润 | 5.61× | — |
| 过去12个月自由现金流最近4个季度 | $347.9M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流HRMYVNET
| Q4 25 | $126.2M | — | ||
| Q3 25 | $108.7M | $113.8M | ||
| Q2 25 | $79.3M | — | ||
| Q1 25 | $34.0M | $27.0M | ||
| Q4 24 | $75.6M | — | ||
| Q3 24 | $70.5M | $108.3M | ||
| Q2 24 | $42.6M | $55.8M | ||
| Q1 24 | $31.1M | $37.1M |
自由现金流HRMYVNET
| Q4 25 | $126.0M | — | ||
| Q3 25 | $108.7M | $-193.1M | ||
| Q2 25 | $79.3M | — | ||
| Q1 25 | $33.9M | $-220.0M | ||
| Q4 24 | $75.0M | — | ||
| Q3 24 | $70.5M | $-95.0M | ||
| Q2 24 | $42.0M | $-81.6M | ||
| Q1 24 | $31.1M | $-102.2M |
自由现金流率HRMYVNET
| Q4 25 | 51.7% | — | ||
| Q3 25 | 45.4% | -53.2% | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 18.3% | -71.1% | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 37.9% | -31.4% | ||
| Q2 24 | 24.3% | -29.8% | ||
| Q1 24 | 20.1% | -38.9% |
资本支出强度HRMYVNET
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 84.6% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | 79.8% | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | 67.3% | ||
| Q2 24 | 0.4% | 50.1% | ||
| Q1 24 | 0.0% | 53.0% |
现金转化率HRMYVNET
| Q4 25 | 5.61× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 1.53× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 3.68× | — | ||
| Q1 24 | 0.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
